Pharmaceutical Industry Articles & Reports

Explains the open targets association score: evidence, source, type and overall levels, harmonic-sum weights, direct vs indirect links, release 26.09 changes and a 2026 sensitivity and sign-off checklist.

Versioned buyer checklist for predictive clinical AI after ONC's October 2026 HTI-5 final rule: 11-row evidence request matrix, FDA vs ONC decision table, scoring rubric, and evidence-gap register for 2026.

SnapGene vs Geneious Prime vs Benchling for 2026 commercial cloning: list prices ($1,945 and $2,350 per user), documented export routes, and a round-trip acceptance test for CRO handoff.

2026 comparison of medical affairs platforms: Anju, Veeva, Sorcero, Within3 and custom builds, with workflow ownership, integration controls, an AI pilot scorecard and a three-year TCO worksheet.

A 2026 explainer on BindingDB assay data leakage: the three-file Reaction Set ID join, assay-context fields, paper-level splits, and a go/no-go evidence pack for a pilot.

Vendor-neutral 2026 comparison of Biacore 8K+, Octet R8 and Carterra LSA: architecture, fitting and review, data export, 2020 study limits, quote-only pricing and a pilot plus cost-per-accepted-interaction model.

Lab scheduling software for biotech in 2026: a decision tree separating booking, capacity planning and workcell orchestration, with product evidence, SiLA 2, GxP checks and a pilot design.

Analysis of the June 2026 VirBench and gget virus work: agent-only accuracy of 16.9% to 91.3%, Claude Opus 4.7 at 83.2% versus 98.3% with a deterministic tool, plus a query contract and validation protocol.

Implementation reference for protocol amendment version control in 2026: clause-to-system matrix, release gates, reconciliation queries and Tufts 215-day overlap data, with ICH E6(R3), FDA and EU rules.

A 2026 validation protocol for Claude in NMR and LC-MS: separates forward prediction, elucidation, raw FID and LC-MS purity, using Anthropic's 20-compound and one-sample results, ICH Q2(R2) and draft Annex 22.

A 2026 guide to the FDA GSRS UNII: precisionFDA and openFDA ingestion, class-specific matching rules, SPL and IDMP mapping limits, with 167,385 record counts and test cases.

Requirements-first comparison of calibration management software for GxP labs: GAGEtrak, IndySoft, Beamex CMX/LOGiCAL, Fluke MET/CAL and GageList, with a scored 2026 URS matrix, demo tests and a three-year TCO model.

A 2026 research acceptance matrix for ClinVar variant classification, separating germline, somatic clinical impact and oncogenicity across SCV, RCV and VCV records, with XML/VCF provenance checks.

A 2026 analysis of Salesforce in Claude for pharma: beta eligibility, conflicting write guidance, OAuth permissions, human approvals, data exclusions, audit evidence, and a measurable CRM pilot plan.

A 2026 guide to FDA import alerts, DWPE and red, green and yellow lists, with supplier triage, source snapshots, entity matching, removal evidence and a reproducible monitoring schema.

Compare clinical supply forecasting software in 2026: Signant, N-SIDE, SAP ICSM and Bluefin on simulation, optimization, RTSM and ERP integration, governance, plus a reference-trial calculation.

A 2026 engineering guide to EU Data Act connected medical devices: scope, Articles 3 to 5, field catalogs, authorized API access, GDPR safeguards, disclosures and release evidence.

FHIR Provenance vs AuditEvent for GxP in 2026: a scenario crosswalk of 11 events, version and signature limits, Part 11 and Annex 11 context, retention anchors, and four test ratios.

A 2026 qualification guide to Claude programmatic tool calling in bioinformatics: 30-day container retention, no ZDR eligibility, allowed_callers behavior, a data-class gate, negative tests, and an A/B cost worksheet.

A 2026 implementation reference for retraction-aware biomedical RAG: Crossref and PubMed event fields, original-versus-notice identifiers, synchronization controls, human review, and executable acceptance tests.

GxP data archiving guide for 2026: compares native retention, controlled viewers, dynamic archives and certified copies by record class, with a restoration protocol and eight verification measures.

Build a reproducible FDA DECRS supplier verification pipeline in 2026: daily snapshots, current vs excluded files, a tiered match rubric, 65-day expiry arithmetic and a human review queue.

Data report on Claude AI pharma R&D automation: Anthropic's Sept 17, 2026 AL0-AL5 index (26% leads), a frozen-basket Pharma R&D Automation Index, oversight metrics and governance triggers for 2026.

Compare Veeva CDB/DQS, Medidata Clinical Data Studio, elluminate and CluePoints in 2026. Examine cross-source review, query write-back, pricing evidence and a synthetic proof-of-concept pack.